Mumbai: In a one of its kind order, a civil court in Navi Mumbai has directed a Haryana-based pharma company to donate seized Ayurvedic drugs worth Rs 28 lakh to government-run hospitals. The court has also slapped a fine of Rs 10,000 on the company for violating the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
The court’s ruling comes in response to the prosecution initiated by State Food and Drugs Administration (FDA). The regulatory authority had seized a stock of the company for wrongful advertisement.
“In September 2017, Navi Mumbai FDA had seized Ayurvedic drugs worth Rs 28 lakh from a Haryana-based company for wrongful advertisement under Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954,” said an official. FDA joint commissioner (Drugs), Thane said the supplier had all the licence to sell the medicines but they sold it on false promises.
“No one can sell medicines under false promises without a disclaimer to consume it under doctors’ prescriptions. The Ayurvedic drugs that we seized made false promises that it would cure diabetes, cancer, high pressure and other diseases. But it is a violation of the Drugs and Magic Remedies Act. So, we seized it and presented the evidence in the court and we won the case,” said VT Paunikar.
He further added that every year they register several such cases under the same act but generally courts just fine the accused. It has often been observed that the same offenders are caught repeating their crime due to the loopholes in the rules. But in this case, we are extremely happy with the verdict. Rules need to be this strict so that the culprits think twice before committing the same crime again and again,” said Paunikar.
FDA commissioner said patients can now procure these medicines from the donated Ayurvedic hospitals showing the prescriptions. “It has been the record-breaking verdict where the court ordered us to distribute the drug to Ayurvedic hospital that would help hundreds of poor patients. The paperwork is in the process and soon, those would be sent,” said Dr Pallavi Dadare, FDA Commissioner.